The purpose of this funding opportunity announcement (FOA) is to support research to continue the development of drug development tools that have an accepted or a reviewable Letter of Intent (LOI) within a drug development tool qualification program within either CBER or CDER.
The grants will be used to further the development of tools that, once qualified, will be made publicly available to fill unmet needs in drug development.
Grantor contact
HHS-FDA
Administering federal agency
Funding summary
93.103
Food and Drug Administration Research